Julie R. Palmer, ScD
Professor
Boston University School of Public Health
Dept of Epidemiology

ScD, Harvard University
MPH, Boston University



Dr. Palmer is a cancer epidemiologist based at the Slone Epidemiology Center, with research projects spanning cancer early detection, etiology, and survivorship. Her primary focus is on elucidating reasons for the disproportionately high incidence of hormone receptor negative breast cancer in African American women and on understanding and reducing racial disparities in breast cancer mortality. She is a founding leader of the Black Women’s Health Study (BWHS), a prospective cohort study of 59,000 African American women who enrolled in 1995 and have been followed by biennial questionnaire since that time. Her breast cancer research within the BWHS includes work on risk prediction models for breast cancer in African American women, identifying differences in childbearing patterns as a contributing cause to the excess incidence of estrogen receptor negative breast cancer in African American women, and investigating the interrelationships of type 2 diabetes, obesity, and inflammation on breast cancer risk. To have greater statistical power for determining genetic and non-genetic factors related to specific molecular subtypes of breast cancer, she and colleagues formed the AMBER Consortium, which includes more than 5,000 African American women with breast cancer and a large number of controls. Dr. Palmer also has an interest in pancreatic cancer, which disproportionately affects African Americans. Currently, she is examining the relation of the oral microbiome to risk of pancreatic cancer in African Americans. Selected leadership activities include 1) Associate Director for Population Sciences, BU-BMC Cancer Center, 2) Chair of the NIH Cancer, Cardiovascular, and Sleep Epidemiology Study Section, 2015-2017, 3) Steering Committee of NCI Cohort Consortium currently and 2004-2011, and 4) Steering Committee of the Molecular Epidemiology Group of AACR, 2018-2020.

Director ad interim
Boston University School of Public Health
BU-BMC Cancer Center


Associate Director for Population Sciences
Boston University School of Public Health
BU-BMC Cancer Center


Associate Director
Boston University School of Public Health
Slone Epidemiology Center



2017 American Association for Cancer Research: AACR Distinguished Lectureship on the Science of Cancer Health Disparities
2011 National Cancer Institute: Outstanding Service Award
2011 Boston University School of Public Health: Distinguished Alumni Award
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Titus L, Hatch EE, Drake KM, Parker SE, Hyer M, Palmer JR, Strohsnitter WC, Adam E, Herbst AL, Huo D, Hoover RN, Troisi R. Reproductive and hormone-related outcomes in women whose mothers were exposed in utero to diethylstilbestrol (DES): A report from the US National Cancer Institute DES Third Generation Study. Reprod Toxicol. 2018 Dec 27; 84:32-38.View Related Profiles. PMID: 30594671.
     
  2. Webb PM, Na R, Weiderpass E, Adami HO, Anderson KE, Bertrand KA, Botteri E, Brasky TM, Brinton LA, Chen C, Doherty JA, Lu L, McCann SE, Moysich KB, Olson S, Petruzella S, Palmer JR, Prizment AE, Schairer C, Setiawan VW, Spurdle AB, Trabert B, Wentzensen N, Wilkens L, Yang HP, Yu H, Risch HA, Jordan SJ. Use of aspirin, other nonsteroidal anti-inflammatory drugs and acetaminophen and risk of endometrial cancer: the Epidemiology of Endometrial Cancer Consortium. Ann Oncol. 2018 Dec 19.View Related Profiles. PMID: 30566587.
     
  3. Nichols HB, Schoemaker MJ, Cai J, Xu J, Wright LB, Brook MN, Jones ME, Adami HO, Baglietto L, Bertrand KA, Blot WJ, Boutron-Ruault MC, Dorronsoro M, Dossus L, Eliassen AH, Giles GG, Gram IT, Hankinson SE, Hoffman-Bolton J, Kaaks R, Key TJ, Kitahara CM, Larsson SC, Linet M, Merritt MA, Milne RL, Pala V, Palmer JR, Peeters PH, Riboli E, Sund M, Tamimi RM, Tjønneland A, Trichopoulou A, Ursin G, Vatten L, Visvanathan K, Weiderpass E, Wolk A, Zheng W, Weinberg CR, Swerdlow AJ, Sandler DP. Breast Cancer Risk After Recent Childbirth: A Pooled Analysis of 15 Prospective Studies. Ann Intern Med. 2018 Dec 11.View Related Profiles. PMID: 30534999.
     
  4. Cozier YC, Yu J, Wise LA, VanderWeele TJ, Balboni TA, Argentieri MA, Rosenberg L, Palmer JR, Shields AE. Religious and Spiritual Coping and Risk of Incident Hypertension in the Black Women's Health Study. Ann Behav Med. 2018 Nov 12; 52(12):989-998.View Related Profiles. PMID: 30418522.
     
  5. Schoemaker MJ, Nichols HB, Wright LB, Brook MN, Jones ME, O'Brien KM, Adami HO, Baglietto L, Bernstein L, Bertrand KA, Boutron-Ruault MC, Braaten T, Chen Y, Connor AE, Dorronsoro M, Dossus L, Eliassen AH, Giles GG, Hankinson SE, Kaaks R, Key TJ, Kirsh VA, Kitahara CM, Koh WP, Larsson SC, Linet MS, Ma H, Masala G, Merritt MA, Milne RL, Overvad K, Ozasa K, Palmer JR, Peeters PH, Riboli E, Rohan TE, Sadakane A, Sund M, Tamimi RM, Trichopoulou A, Ursin G, Vatten L, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Yuan JM, Zeleniuch-Jacquotte A, Sandler DP, Swerdlow AJ. Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women. JAMA Oncol. 2018 Nov 01; 4(11):e181771.View Related Profiles. PMID: 29931120.
     
  6. Petrick JL, Thistle JE, Zeleniuch-Jacquotte A, Zhang X, Wactawski-Wende J, Van Dyke AL, Stampfer MJ, Sinha R, Sesso HD, Schairer C, Rosenberg L, Rohan TE, Robien K, Purdue MP, Poynter JN, Palmer JR, Newton CC, Linet MS, Liao LM, Lee IM, Koshiol J, Kitahara CM, Hofmann JN, Graubard BI, Giovannucci E, Gaziano JM, Gapstur SM, Freedman ND, Chong DQ, Chan AT, Buring JE, Beane Freeman LE, Campbell PT, McGlynn KA. Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysis. Am J Gastroenterol. 2018 Oct; 113(10):1494-1505.View Related Profiles. PMID: 30177781.
     
  7. Uribe-Salazar JM, Palmer JR, Haddad SA, Rosenberg L, Ruiz-Narváez EA. Admixture mapping and fine-mapping of type 2 diabetes susceptibility loci in African American women. J Hum Genet. 2018 Nov; 63(11):1109-1117. PMID: 30135545.
     
  8. Troisi R, Hatch EE, Palmer JR, Titus L, Sampson JN, Xu X, Hoover RN. Estrogen Metabolism in Postmenopausal Women Exposed In Utero to Diethylstilbestrol. Cancer Epidemiol Biomarkers Prev. 2018 Oct; 27(10):1208-1213.View Related Profiles. PMID: 30049842.
     
  9. Ochs-Balcom HM, Shaw H, Preus L, Palmer JR, Haddad SA, Rosenberg L, Ruiz-Narváez EA. Admixture mapping and fine-mapping of birth weight loci in the Black Women's Health Study. Hum Genet. 2018 Jul 13. PMID: 30006737.
     
  10. Haddad SA, Ruiz-Narváez EA, Cozier YC, Gerlovin H, Rosenberg L, Palmer JR. Association of Degree of European Genetic Ancestry With Serum Vitamin D Levels in African Americans. Am J Epidemiol. 2018 Jul 01; 187(7):1420-1423.View Related Profiles. PMID: 29390092.
     
Showing 10 of 348 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 348 publications over 33 distinct years, with a maximum of 34 publications in 2016

YearPublications
19861
19872
19882
19895
19907
19916
19925
19934
19943
19955
19962
19973
19985
19996
20008
20019
20025
20039
20045
200510
200616
200714
20089
200911
201018
201115
201220
201325
201417
201521
201634
201725
201821
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

cancer epidemiology
health disparities
breast cancer subtypes
Contact for Mentoring:


1010 Commonwealth Ave
Boston MA 02215
Google Map


Palmer's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department